ETF · iShares · IBB

iShares Biotechnology ETF

iShares Biotechnology ETF (IBB) is an ETF from iShares that tracks the NYSE Biotechnology Index index. Its ongoing charge is 0.44% a year and it holds $10.7bn in assets. The fund uses physical replication, is distributing, is domiciled in United States.

IBB in figures

Assets
$10.7bn
Ongoing charge (TER)
0.44%
Holdings
243
Weight of the ten largest
52.1%
Dividend yield
0.4%
Return, year to date (USD)
+26.0%
Return, 1 year (USD)
+30.4%
Return, 3 years a year (USD)
+22.0%
Return, 5 years a year (USD)
+6.9%
Volatility, 3 years (USD)
21.6%

Figures as of 13 November 2026. Past performance does not predict future returns. Information only, not investment advice.

Fund facts

Issuer
iShares
Index
NYSE Biotechnology Index
Asset class
Equity, Sector
Region
US
Replication
Physical
Income
distributing
Domicile
United States
Currency hedged
No
Launched
5 February 2001
ISIN
US4642875565

Largest holdings

GILEAD SCIENCES9.1%
AMGEN INC8.5%
VERTEX PHARMACEUTICALS7.9%
REGENERON PHARMACEUTICALS6.3%
MODERNA6.2%
ARGENX SE ADR3.5%
NATERA3.4%
BIOGEN2.5%
REVOLUTION MEDICINES2.4%
BEONE MEDICINES AG2.3%

Sectors

Biotechnology87.5%
Life Sciences Tools & Services9.6%
Pharmaceuticals2.7%
Health Care Services0.1%
Cash and/or Derivatives0.1%
Health Care Equipment0.1%

Countries

United States94.4%
Denmark2.1%
United Kingdom1.5%
Canada0.5%
France0.4%
Switzerland0.3%
Netherlands0.3%
China0.1%
Spain0.1%
Ireland0.1%